Published in Stroke on March 01, 2002
Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis. Am J Epidemiol (2009) 1.60
Relative importance of systemic determinants of retinal arteriolar and venular caliber: the atherosclerosis risk in communities study. Arch Ophthalmol (2008) 1.25
Retinal vascular caliber and risk of dementia: the Rotterdam study. Neurology (2011) 1.15
Ocular ischemic syndrome - a systematic review. Med Sci Monit (2012) 1.11
Eye syndromes and the neuro-ophthalmology of stroke. Handb Clin Neurol (2009) 0.90
Neovascular Glaucoma Post Carotid Endarterectomy: A Case Report and Review of the Literature. Ann Vasc Dis (2015) 0.82
Complete occlusion of extracranial internal carotid artery: clinical features, pathophysiology, diagnosis and management. Postgrad Med J (2007) 0.81
Compensatory patterns of collateral flow in stroke patients with unilateral and bilateral carotid stenosis. BMC Neurol (2016) 0.80
[Ocular ischemic syndrome]. Ophthalmologe (2011) 0.78
Cerebral revascularization with superficial temporal - middle cerebral artery anastomosis for complete carotid occlusion: An emerging modality for preventing recurrent stroke. Ann Indian Acad Neurol (2013) 0.75
Vascular neuro-ophthalmology. Neurol Clin (2010) 0.75
Transient monocular blindness: the controversial role of the ophthalmic artery--response to Rutgers et al. in J Neurol (2003) 250:501-502. J Neurol (2004) 0.75
A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med (2014) 18.12
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet (2010) 11.00
Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol (2007) 6.15
Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol (2010) 5.79
A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. The Dutch TIA Trial Study Group. N Engl J Med (1991) 5.69
Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data. Lancet (2010) 4.07
Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol (2012) 3.93
Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol (2009) 3.89
Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis. N Engl J Med (2006) 3.80
Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol (2011) 3.73
Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol (2009) 3.66
Risk of rupture of unruptured intracranial aneurysms in relation to patient and aneurysm characteristics: an updated meta-analysis. Stroke (2007) 3.59
Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. JAMA (2011) 3.40
The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care (2005) 3.36
Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol (2009) 3.36
New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS). Lancet Neurol (2010) 3.35
Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. Lancet (2012) 3.14
National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol (2006) 2.82
The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial. Lancet Neurol (2009) 2.78
Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes (2006) 2.77
Seventy-five genetic loci influencing the human red blood cell. Nature (2012) 2.77
Clinical practice. Acute ischemic stroke. N Engl J Med (2007) 2.76
Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk. Circulation (2008) 2.42
Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke (2005) 2.41
Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage. Lancet Neurol (2011) 2.38
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol (2009) 2.37
Preoperative diagnosis of carotid artery stenosis: accuracy of noninvasive testing. Stroke (2002) 2.37
Asymptomatic carotid artery stenosis and the risk of new vascular events in patients with manifest arterial disease: the SMART study. Stroke (2007) 2.36
C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat Genet (2007) 2.35
Treatment of space-occupying cerebral infarction. Crit Care Med (2003) 2.14
Nurses' prediction of volume status after aneurysmal subarachnoid haemorrhage: a prospective cohort study. Crit Care (2008) 2.06
Magnetic resonance imaging for quantitative flow measurement in infants with hydrocephalus: a prospective study. J Neurosurg Pediatr (2008) 2.05
Impaired glucose tolerance increases stroke risk in nondiabetic patients with transient ischemic attack or minor ischemic stroke. Stroke (2006) 1.99
Homozygosity mapping in patients with cone-rod dystrophy: novel mutations and clinical characterizations. Invest Ophthalmol Vis Sci (2010) 1.98
Trigger factors and their attributable risk for rupture of intracranial aneurysms: a case-crossover study. Stroke (2011) 1.96
Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur J Pharmacol (2008) 1.91
Genotype and phenotype of 101 dutch patients with congenital stationary night blindness. Ophthalmology (2013) 1.87
Growth rates of intracranial aneurysms: exploring constancy. J Neurosurg (2008) 1.85
Meta-analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24.12. Neurology (2014) 1.85
High VWF, low ADAMTS13, and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women. Blood (2011) 1.78
Timing of aneurysm surgery in subarachnoid hemorrhage: a systematic review of the literature. Neurosurgery (2002) 1.76
Carotid stiffness and the risk of new vascular events in patients with manifest cardiovascular disease. The SMART study. Eur Heart J (2005) 1.75
Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev (2010) 1.74
Homozygosity mapping reveals PDE6C mutations in patients with early-onset cone photoreceptor disorders. Am J Hum Genet (2009) 1.72
Overestimation of risk ratios by odds ratios in trials and cohort studies: alternatives to logistic regression. CMAJ (2011) 1.70
Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial. Blood (2003) 1.70
Comparison of telephone and face-to-face assessment of the modified Rankin Scale. Cerebrovasc Dis (2009) 1.69
Genetic etiology and clinical consequences of complete and incomplete achromatopsia. Ophthalmology (2009) 1.65
Imaging of carotid arteries in symptomatic patients: cost-effectiveness of diagnostic strategies. Radiology (2004) 1.64
Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol (2012) 1.63
The spectrum of presentations of venous infarction caused by deep cerebral vein thrombosis. Neurology (2005) 1.61
Progressive loss of cones in achromatopsia: an imaging study using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci (2010) 1.61
Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes. Diabetes Care (2010) 1.61
Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition. Biochim Biophys Acta (2008) 1.60
The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J (2004) 1.59
Trends in worldwide volume and methodological quality of surgical randomized controlled trials. Ann Surg (2013) 1.50
Cerebral microinfarcts: a systematic review of neuropathological studies. J Cereb Blood Flow Metab (2012) 1.47
Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke. Lancet (2011) 1.46
Excimer laser-assisted nonocclusive anastomosis. An emerging technology for use in the creation of intracranial-intracranial and extracranial-intracranial cerebral bypass. Neurosurg Focus (2008) 1.46
Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database Syst Rev (2015) 1.46
Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2013) 1.45
Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes. Diabetes (2006) 1.44
Blood pressure and progression of cerebral atrophy in patients with vascular disease. Am J Hypertens (2009) 1.41
Prevalence of intracranial large artery stenosis and occlusion in patients with acute ischaemic stroke or TIA. Neurol Sci (2014) 1.41
Prothrombotic gene variation in patients with large and small vessel disease. Neuroepidemiology (2008) 1.40
Comprehensive analysis of the achromatopsia genes CNGA3 and CNGB3 in progressive cone dystrophy. Ophthalmology (2010) 1.40
Epilepsy surgery in tuberous sclerosis: a systematic review. Epilepsia (2007) 1.39
Cost-effectiveness of preventive treatment of intracranial aneurysms: new data and uncertainties. Neurology (2009) 1.39
[Secondary prevention with clopidogrel after TIA or stroke]. Ned Tijdschr Geneeskd (2013) 1.39
Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis (2004) 1.38
Cerebral cortical thickness in patients with type 2 diabetes. J Neurol Sci (2010) 1.34
Clinical course, genetic etiology, and visual outcome in cone and cone-rod dystrophy. Ophthalmology (2012) 1.34
Interferon-beta blocks infiltration of inflammatory cells and reduces infarct volume after ischemic stroke in the rat. J Cereb Blood Flow Metab (2003) 1.33
Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic arterial disease. Stroke (2008) 1.33
Time is brain(stem) in basilar artery occlusion. Stroke (2012) 1.31
Limb-shaking transient ischaemic attacks in patients with internal carotid artery occlusion: a case-control study. Brain (2010) 1.30
Prognosis of haemorrhagic stroke in childhood: a long-term follow-up study. Dev Med Child Neurol (2003) 1.30
Disruption of the cerebral white matter network is related to slowing of information processing speed in patients with type 2 diabetes. Diabetes (2013) 1.29
Intraoperative hypotension and perioperative ischemic stroke after general surgery: a nested case-control study. Anesthesiology (2012) 1.28
Internal carotid artery occlusion assessed at pulsed arterial spin-labeling perfusion MR imaging at multiple delay times. Radiology (2004) 1.27